Wen‐Fang Cheng

10.5k total citations
291 papers, 8.1k citations indexed

About

Wen‐Fang Cheng is a scholar working on Molecular Biology, Reproductive Medicine and Obstetrics and Gynecology. According to data from OpenAlex, Wen‐Fang Cheng has authored 291 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Molecular Biology, 75 papers in Reproductive Medicine and 70 papers in Obstetrics and Gynecology. Recurrent topics in Wen‐Fang Cheng's work include Ovarian cancer diagnosis and treatment (62 papers), Endometrial and Cervical Cancer Treatments (60 papers) and Immunotherapy and Immune Responses (45 papers). Wen‐Fang Cheng is often cited by papers focused on Ovarian cancer diagnosis and treatment (62 papers), Endometrial and Cervical Cancer Treatments (60 papers) and Immunotherapy and Immune Responses (45 papers). Wen‐Fang Cheng collaborates with scholars based in Taiwan, China and United States. Wen‐Fang Cheng's co-authors include Chi‐An Chen, T.‐C. Wu, Chien‐Fu Hung, Yu‐Li Chen, Morris Ling, Chang‐Yao Hsieh, Chee‐Yin Chai, Ying‐Cheng Chiang, Keng‐Fu Hsu and Chien‐Nan Lee and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Wen‐Fang Cheng

278 papers receiving 7.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen‐Fang Cheng Taiwan 50 3.2k 2.2k 1.7k 1.6k 1.4k 291 8.1k
Any Cheung Hong Kong 55 4.5k 1.4× 844 0.4× 1.8k 1.1× 1.6k 1.0× 1.7k 1.2× 311 9.5k
Daisuke Aoki Japan 47 3.6k 1.1× 1.3k 0.6× 2.5k 1.5× 2.0k 1.2× 1.7k 1.2× 440 11.0k
Estrid Høgdall Denmark 48 2.4k 0.8× 660 0.3× 2.1k 1.2× 1.6k 1.0× 687 0.5× 325 7.3k
Sharon P. Wilczynski United States 45 2.0k 0.6× 698 0.3× 1.9k 1.1× 888 0.5× 1.9k 1.4× 127 6.3k
Masaki Mandai Japan 49 2.9k 0.9× 3.6k 1.6× 4.6k 2.7× 1.2k 0.8× 554 0.4× 354 10.7k
Peter Kenemans Netherlands 56 2.6k 0.8× 2.2k 1.0× 2.4k 1.4× 780 0.5× 2.4k 1.7× 304 11.6k
Sepp Leodolter Austria 38 1.5k 0.5× 616 0.3× 1.2k 0.7× 724 0.4× 1.9k 1.3× 181 5.5k
Wolfram Ruf United States 70 4.0k 1.2× 2.4k 1.1× 1.3k 0.8× 2.2k 1.3× 1.1k 0.8× 280 15.7k
Ronald D. Alvarez United States 63 4.6k 1.4× 1.6k 0.7× 4.3k 2.5× 779 0.5× 2.0k 1.4× 340 12.5k
Kei Kawana Japan 37 1.2k 0.4× 1.1k 0.5× 755 0.4× 403 0.2× 1.3k 0.9× 206 4.2k

Countries citing papers authored by Wen‐Fang Cheng

Since Specialization
Citations

This map shows the geographic impact of Wen‐Fang Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Fang Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Fang Cheng more than expected).

Fields of papers citing papers by Wen‐Fang Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen‐Fang Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Fang Cheng. The network helps show where Wen‐Fang Cheng may publish in the future.

Co-authorship network of co-authors of Wen‐Fang Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Wen‐Fang Cheng. A scholar is included among the top collaborators of Wen‐Fang Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen‐Fang Cheng. Wen‐Fang Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Chun‐Yu, Ting‐Chun Kuo, Han-Wei Lin, et al.. (2024). Immunocyte profiling changes in patients received epidural versus intravenous analgesia after pancreatectomy: A randomized controlled trial. Journal of the Formosan Medical Association. 124(1). 50–56. 1 indexed citations
2.
Fu, Dian, Bo Yang, Ming Yang, et al.. (2023). Misdiagnosis of renal pelvic unicentric Castleman disease: a case report. Frontiers in Surgery. 10. 1225890–1225890.
4.
Sun, Wei‐Zen, Han-Wei Lin, Chen Wy, et al.. (2023). Dual inhibition of BTLA and PD-1 can enhance therapeutic efficacy of paclitaxel on intraperitoneally disseminated tumors. Journal for ImmunoTherapy of Cancer. 11(7). e006694–e006694. 7 indexed citations
5.
Chou, Hung‐Hsueh, Sián Fereday, Anna DeFazio, et al.. (2022). Contrasting clinical characteristics and treatment patterns in women with newly diagnosed advanced-stage epithelial ovarian cancer in Australia, South Korea and Taiwan. Journal of Gynecologic Oncology. 34(1). e3–e3. 2 indexed citations
6.
Chen, Jenny Ling‐Yu, Chao‐Yuan Huang, Yu‐Sen Huang, et al.. (2021). Real-World Evaluation of Modern Adjuvant Radiotherapy in Women with Stage IB Endometrial Cancer. Cancers. 13(6). 1386–1386. 1 indexed citations
8.
Li, Yiping, et al.. (2018). Primary Ewing Family of Tumor Arising in the Ovary: A Case Report. International Journal of Gynecological Pathology. 38(5). 470–473. 2 indexed citations
9.
Lu, Mingjie, Tongshan Wang, Mingfeng He, et al.. (2017). Tumor suppressor role of miR-3622b-5p in ERBB2-positive cancer. Oncotarget. 8(14). 23008–23019. 15 indexed citations
10.
Huang, Zebo, Danxia Zhu, Lirong Wu, et al.. (2016). Six Serum-Based miRNAs as Potential Diagnostic Biomarkers for Gastric Cancer. Cancer Epidemiology Biomarkers & Prevention. 26(2). 188–196. 114 indexed citations
11.
Song, Liwen, Jayne Knoff, Liangmei He, et al.. (2014). Toll-like Receptor Agonist Imiquimod Facilitates Antigen-Specific CD8+ T-cell Accumulation in the Genital Tract Leading to Tumor Control through IFNγ. Clinical Cancer Research. 20(21). 5456–5467. 50 indexed citations
12.
Huang, Chia‐Yen, et al.. (2013). Impact of lymphadenectomy in uterine endometrioid carcinoma. European Journal of Surgical Oncology. 39(4). 350–357. 29 indexed citations
13.
Huang, Yu-Fang, et al.. (2013). Circulating IGF system and treatment outcome in epithelial ovarian cancer. Endocrine Related Cancer. 21(2). 217–229. 39 indexed citations
14.
Chiang, Ying‐Cheng, et al.. (2013). Epigenetic silencing of BLU through interfering apoptosis results in chemoresistance and poor prognosis of ovarian serous carcinoma patients. Endocrine Related Cancer. 20(2). 213–227. 16 indexed citations
15.
Tian, Jinwei, Yanli Sun, Wen‐Fang Cheng, et al.. (2012). Abstract 17934: Bevacizumab for Plaque Stabilization: Evaluation of its Effect on Vasa Vasorum, Lipid Pool, and Atheroma Volume by Multimodality Imaging Techniques in an Atherosclerotic Rabbit Model. Circulation. 3 indexed citations
16.
Cheng, Wen‐Fang, Chien‐Fu Hung, Chee‐Yin Chai, et al.. (2007). Generation and characterization of an ascitogenic mesothelin‐expressing tumor model. Cancer. 110(2). 420–431. 19 indexed citations
17.
Lee, Chien‐Nan, Yi‐Ning Su, Wen‐Fang Cheng, et al.. (2005). Association of the C677T methylenetetrahydrofolate reductase mutation with congenital heart diseases. Acta Obstetricia Et Gynecologica Scandinavica. 84(12). 1134–1140. 3 indexed citations
18.
Tsao, Po‐Nien, Yi‐Ning Su, Hung Li, et al.. (2003). Overexpression of Placenta Growth Factor Contributes to the Pathogenesis of Pulmonary Emphysema. American Journal of Respiratory and Critical Care Medicine. 169(4). 505–511. 72 indexed citations
19.
Chen, Chi‐An, Wen‐Fang Cheng, Lin‐Hung Wei, Yi‐Ning Su, & Chang‐Yao Hsieh. (2002). Radical hysterectomy alone or combined with neoadjuvant chemotherapy in the treatment of early stage bulky cervical carcinoma.. PubMed. 101(3). 195–202. 13 indexed citations
20.
Cheng, Wen‐Fang, Chien‐Fu Hung, Chee‐Yin Chai, et al.. (2001). Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen. Journal of Clinical Investigation. 108(5). 669–678. 215 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026